CSF1R and glioblastoma: Additionally, the monoclonal antibody (mAb) RG7155 against CSF1R reduce TAM recruitment.85 The CSF1R inhibitor BLZ945 reduced M2-associated genes such as arginase 1 and CD206 in a mouse proneural glioblastoma model.